UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Up 5.1% Today

What is UnitedHealth Group Incorporated (DE)?

UnitedHealth (UNH) is a leading healthcare company offering a wide range of health benefits services. The overall market sentiment in the healthcare sector appears positive, with a focus on strong financial performance and strategic initiatives driving growth.

Why is UnitedHealth Group Incorporated (DE) going up?

UNH stock is up 5.1% on Apr 28, 2026 16:15

• UnitedHealth (UNH) saw a significant uptrend after receiving positive evaluations from analysts and amid favorable sentiment in the healthcare sector.
• The company's robust performance in its Medicaid, Medicare, and Marketplace segments, along with strategic initiatives, likely contributed to the optimistic market movement.
• Analysts' positive evaluations and higher price targets reflect confidence in UnitedHealth's future prospects and financial outlook.
• Emphasis on patient safety culture and leadership in healthcare systems may have also positively impacted investor sentiment towards companies like UnitedHealth, which are recognized for their commitment to quality care and value-based services.

UNH Price Chart

UNH Technical Analysis

UNH News

Full Transcript: Centene Q1 2026 Earnings Call

Centene (NYSE: CNC) reported strong Q1 2026 adjusted diluted EPS of $3.37, surpassing expectations and leading to an increased full-year EPS guidance of over $3.40. The company saw excellent performance in its Medicaid, Medicare, and Marketplace segments, with strategic initiatives in trend management, fraud prevention, and value-based care driving positive results. Centene also announced leadership structure changes and highlighted progress in balance sheet improvement through debt reduction.

https://www.benzinga.com/insights/news/26/04/52096778/full-transcript-centene-q1-2026-earnings-call

3 steps for health system leaders to drive patient safety culture

Health system leaders can foster a stronger patient safety culture by implementing robust reporting systems, ensuring clear communication of corrective actions, and actively involving staff in safety improvements. The article emphasizes that authentic leadership and a non-punitive approach are crucial for shifting from traditional hierarchical structures to a just culture where most medical errors are attributed to system flaws rather than individual negligence. By making reporting easier, following through on feedback, and engaging with frontline staff, leaders can build trust and improve patient outcomes and staff retention.

https://www.techtarget.com/patientengagement/feature/3-steps-for-health-system-leaders-to-drive-patient-safety-culture

Analysts Are Bullish on Top Healthcare Stocks: UnitedHealth (UNH), Eli Lilly & Co (LLY)

Three analysts from Mizuho Securities and Truist Financial have issued bullish ratings for UnitedHealth (UNH), Eli Lilly & Co (LLY), and Erasca (ERAS). UnitedHealth received a Buy rating with a $410 price target from Ann Hynes, while Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co. Joseph Catanzaro also maintained a Buy rating on Erasca with a $28 price target.

https://www.theglobeandmail.com/investing/markets/stocks/UNH/pressreleases/1558683/analysts-are-bullish-on-top-healthcare-stocks-unitedhealth-unh-eli-lilly-co-lly/

Franklin Resources brought in $16.9B as quarterly profit rose to $268M

Franklin Resources Inc. reported a significant rise in its second-quarter net income to $268.2 million, or $0.49 per diluted share, for the quarter ended March 31, 2026, compared to $151.4 million a year ago. The company also announced strong long-term net inflows of $16.9 billion, driven by diverse contributions from both public and private markets, as well as record assets under management for ETFs and Canvas. CEO Jenny Johnson highlighted the strength of their global platform, improved gross sales across all asset classes, and positive long-term net flows in every region.

https://www.stocktitan.net/news/BEN/franklin-resources-inc-announces-second-quarter-uhz65k04nd26.html

Centene Reports Strong Q1 Earnings, Raises Guidance

Centene reported strong Q1 earnings, with non-GAAP EPS of $3.37 surpassing expectations by $1.24 and revenue reaching $49.94 billion, a 7.1% year-over-year increase. The company also raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, and updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40. Analysts have reacted by modest price target increases, with Jefferies raising their target to $39 and BofA to $34, though both maintained their current ratings.

https://intellectia.ai/news/stock/centene-reports-strong-q1-earnings-raises-guidance

Trending Today

Wheat ($WHEAT) Commodity Forecast: Up 5.2% Today

Tilray Inc. ($TLRY) Stock Forecast: Down 5.3% Today

Incyte Corporation ($INCY) Stock Forecast: Up 1.3% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 7.3% Today

United Parcel Service Inc. ($UPS) Stock Forecast: Down 4.9% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.2% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.1% Today

Universal Health Services Inc. ($UHS) Stock Forecast: Down 6.9% Today

Albemarle Corporation ($ALB) Stock Forecast: Down 5.1% Today

UnitedHealth Group Incorporated (DE) Price History

24.01.2026 - UNH Stock was down 5.0%

• UNH stock dipped 2.64% today, underperforming broader market indices like the S&P 500, Dow, and Nasdaq.
• Analysts anticipate a decline in EPS for the upcoming release, signaling potential concerns about the company's financial performance.
• The bearish movement could be attributed to general market volatility, concerns about healthcare regulatory risks, and potentially lower-than-expected financial results for the company.

24.01.2026 - UNH Stock was down 5.2%

• Today's bearish movement in UNH stock could be explained by:
• Concerns related to regulatory challenges and policy uncertainties impacting the healthcare sector, leading to a broader decline in healthcare stocks.
• DaVita Inc.'s strong earnings report and potential as a competitor in the healthcare space possibly diverting investor attention away from UNH.
• Weaker-than-expected earnings from Humana Inc. and the changing regulatory landscape in the healthcare industry potentially influencing negative market sentiment towards UNH and other healthcare stocks.
• The focus on affordability and value-based care in the healthcare industry, as emphasized by Humana's President, possibly raising worries about profit margins for companies like UNH amidst rising cost pressures.

28.03.2026 - UNH Stock was up 5.1%

• UnitedHealth (UNH) saw a significant uptrend after receiving positive evaluations from analysts and amid favorable sentiment in the healthcare sector.
• The company's robust performance in its Medicaid, Medicare, and Marketplace segments, along with strategic initiatives, likely contributed to the optimistic market movement.
• Analysts' positive evaluations and higher price targets reflect confidence in UnitedHealth's future prospects and financial outlook.
• Emphasis on patient safety culture and leadership in healthcare systems may have also positively impacted investor sentiment towards companies like UnitedHealth, which are recognized for their commitment to quality care and value-based services.

27.02.2026 - UNH Stock was down 5.0%

• UNH stock declined by 3.14% due to persistent bearish momentum driven by regulatory and legal challenges, leading to a single-digit profit decline projection for the upcoming quarter.
• Analysts expect a profit decrease year-over-year for UNH's next earnings report, attributing underperformance to challenges like higher medical costs and declining Medicare Advantage enrollment.
• The bearish trend in UNH stock is further confirmed by technical indicators, signaling a high probability of continued downside unless the stock breaks decisively above $281.
• The positive movements in CVS Health Corporation (CVS), Boston Scientific Corp (BSX), and iRhythm Technologies did not directly impact UNH's bearish movement, as each company has its own unique growth drivers and catalysts influencing their stock performance.

21.03.2026 - UNH Stock was up 9.4%

• UnitedHealth Group's stock saw a strong bullish movement recently.
• The stock jumped 8% after releasing better-than-expected first-quarter results, driven by improved cost management and more favorable Medicare Advantage payment rates.
• Despite challenges in the Medicare obesity drug pilot program, UnitedHealth's positive financial performance and outlook contributed to the stock's significant increase.
• The company's participation in the program's short-term demo phase for obesity drugs at negotiated prices also added to investor confidence in UnitedHealth's resilience and growth potential.

21.03.2026 - UNH Stock was up 8.5%

• UnitedHealth Group (UNH) stock experienced a significant 9% rally following better-than-expected first-quarter results, with a 2% revenue growth and flat adjusted EPS. The company also raised its 2026 adjusted EPS outlook, boosting investor confidence.
• Positive earnings and rate actions improving the medical cost ratio were key drivers of the stock's bullish movement, indicating operational efficiency and financial strength.
• The overall market sentiment was positive, with other major stocks like Valmont Industries (VMI) also posting upbeat Q1 results, contributing to a bullish trend in the healthcare sector.
• The acceptance of Aprea Therapeutics' abstract for presentation at the ASCO 2026 Annual Meeting could have also positively influenced investor sentiment towards healthcare stocks, including UnitedHealth Group.

21.03.2026 - UNH Stock was up 11.0%

• UnitedHealth Group reported better-than-expected first-quarter results, leading to a 9% stock rally, driven by a 2% revenue growth and flat adjusted EPS.
• The company raised its 2026 adjusted EPS outlook due to an improving medical cost ratio from repricing at-risk plans, boosting investor confidence.
• Despite operational and regulatory risks, UnitedHealth Group maintains a moderately undervalued rating with a $427 fair value estimate, indicating positive sentiment towards the stock.
• The bullish movement in UNH stock can be attributed to the company's strong financial performance and optimistic outlook, showcasing resilience in the healthcare sector amidst ongoing challenges.

21.03.2026 - UNH Stock was up 9.2%

• UnitedHealth raised its full-year adjusted earnings guidance by 50 cents per share, demonstrating confidence in its financial performance and trajectory. This led to a more than 7% jump in its shares during pre-market trading.
• Optum's clinical policy expansion to include nurse practitioners in administering transcranial magnetic stimulation therapy is a strategic move to enhance healthcare access and treatment options. This move potentially contributed to UnitedHealth's positive market movement.
• The overall bullish sentiment in the market, as seen with the S&P 500 futures climbing in pre-market trading, likely supported UnitedHealth's stock surge, reflecting a positive start for U.S. stock markets today.

07.03.2026 - UNH Stock was up 8.2%

• UNH's stock surged following a positive decision regarding Medicare rates, surpassing the $300 mark. However, it encountered resistance in the $300 to $400 range.
• The decision to raise Medicare insurer payments substantially has boosted investor confidence in health insurance stocks, such as UNH, Humana, and CVS Health.
• The market movement can be attributed to the positive impact of the revised Medicare Advantage payment plan, expected to inject an additional $13 billion into the private health insurance industry by 2027.
• Investors are upbeat about UNH's future, with optimists focusing on cost-saving initiatives and AI utilization, while pessimists express worries about potential declines in Medicare Advantage membership.

07.03.2026 - UNH Stock was up 10.7%

• UnitedHealth Group's stock surged over 7% as the Centers for Medicare & Medicaid Services decided to increase Medicaid reimbursement rates by 2.48%, which exceeded analyst expectations. This development is expected to support UnitedHealth's margins and benefit other health insurers like CVS Health and Alignment Healthcare.
• The CMS' MA rate boost for 2027, with a 2.48% increase, has alleviated pressure on the managed care sector due to challenges such as rising utilization and cost pressures. UnitedHealth's scale and integrated Optum platform position the company well for future profitability.
• Despite facing near-term membership declines in pursuit of profitability, UnitedHealth is anticipated to benefit from the rate hike and maintain its positive momentum in the market.

07.03.2026 - UNH Stock was up 9.2%

• Following a 2.48% rate increase for Medicare Advantage plans by the Centers for Medicare and Medicaid Services (CMS) in 2027, UnitedHealth's stock witnessed a significant upturn surpassing predictions. This positive development not only bolstered UnitedHealth but also lifted other health insurer stocks such as Humana and Centene.
• UnitedHealth stands to benefit notably from the favorable rate update, coupled with its extensive scale and integrated Optum platform, positioning the company favorably to leverage the heightened payments.
• While grappling with imminent membership declines to enhance profitability, UnitedHealth's stock soared as investors perceived the CMS rate hike as a beneficial move alleviating some industry pressures.
• This market response underscores how regulatory decisions and industry-specific updates can markedly influence individual company stocks, emphasizing the significance of monitoring sector-related updates and government policies for informed trading choices.

07.03.2026 - UNH Stock was up 9.4%

• UNH stock rose notably after the government's decision to enhance Medicare insurer payments, which positively impacted health insurance companies.
• Bernstein's raised price target of $411 for UNH, along with maintaining an Outperform rating, contributed to increased investor confidence.
• The overall optimism towards UNH was mirrored in the market, with other health insurance firms like Humana Inc. also experiencing significant gains.
• UNH's bullish trajectory is linked to favorable regulatory changes and positive analyst forecasts, instilling confidence in the healthcare sector among investors.